Literature DB >> 9299475

Identification of glucose-regulated genes in human mesangial cells by mRNA differential display.

D I Holmes1, N Abdel Wahab, R M Mason.   

Abstract

Diabetic nephropathy is characterised by an accumulation of extracellular matrix proteins in the glomerular mesangium. Hyperglycaemia is a major factor promoting this progressive expansion of the mesangial matrix. We have used the technique of mRNA differential display to investigate changes in gene expression in cultured human mesangial cells following long-term (21 days) exposure to either physiologic (4 mM) or pathologic (30 mM) D-glucose concentrations. Approximately 12,000 mRNA species were screened for evidence of altered expression and several hundred candidate cDNA fragments were obtained. Northern blot and RT-PCR analysis of ten randomly chosen candidate cDNA fragments revealed three exhibiting increased mRNA expression under elevated D-glucose levels. Nucleotide sequence analysis identified two of the cDNA fragments as encoding prolyl 4-hydroxylase alpha-subunit and thrombospondin-1. The third cDNA fragment represents a novel glucose-regulated gene, encoding a putative zinc finger protein. Upregulated expression of these genes in response to high levels of D-glucose may contribute significantly to the disease process. mRNA differential display is a useful tool to investigate the mechanism of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299475     DOI: 10.1006/bbrc.1997.7265

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.

Authors:  David R Clemmons; Laura A Maile; Yan Ling; J Yarber; Walker H Busby
Journal:  Growth Horm IGF Res       Date:  2007-04-06       Impact factor: 2.372

Review 3.  The roles of integrins in mediating the effects of mechanical force and growth factors on blood vessels in hypertension.

Authors:  Jun-Tzu Chao; Michael J Davis
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

4.  Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

Authors:  N A Wahab; L Schaefer; B S Weston; O Yiannikouris; A Wright; A Babelova; R Schaefer; R M Mason
Journal:  Diabetologia       Date:  2005-11-04       Impact factor: 10.122

Review 5.  Gene expression in diabetic nephropathy.

Authors:  Daniela Hohenadel; Fokko J van der Woude
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

Review 6.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

7.  Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.

Authors:  Yanqing Zhu; Hitomi Kataoka Usui; Kumar Sharma
Journal:  Semin Nephrol       Date:  2007-03       Impact factor: 5.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.